Stock LLM Wiki

報告_Citi_致茂2360_20261006

更新 2026-10-07

PDF 原檔:報告_Citi_致茂2360_20261006_original.pdf

圖片清單(已驗證 2026-10-07)

檔名 size 分類 親眼所見內容
報告_Citi_致茂2360_20261006_004.png 229KB 真資料圖 Citi 評等與目標價沿革圖+短線觀點沿革圖(2023–2026,TP 由 330 至 2,500 的歷次紀錄;股價圖)

原始內容

[讀者資訊已遮蔽] citi

Chroma ATE (2360.TW)

3Q26 Another Strong Beat; September Revenue 3x YoY

CITI'S TAKE

Chroma ATE reported Sep revenue that tripled YoY to NT$6,860mn (+22% MoM), concluding 3Q26 with revenue of NT$17,926mn (+180% YoY/+32% QoQ), another quarterly record and beating Street/Citi estimates by 23%/25%, respectively. We believe the robust revenue was mainly driven by datacenter power testers (HDVC, China's ESS build) and photonics (CPO ramp-up), and the 3Q revenue beat suggests upside to Street estimates for FY26 and FY27. Looking ahead, we expect robust AI-driven revenue growth to continue for Chroma across segments, including power tester (HVDC), SLT (GPU & ASIC), metrology (CoWoS, panel), and photonics. CPO shipment remains at an early stage and could expand several times next year. New products in metrology, FT handler, burn-in system could see more meaningful contribution starting 2027. We maintain our positive view and Buy rating for Chroma.

Figure 1. Chroma ATE - Monthly Revenue Trend

© 2026 Citigroup Inc. No redistribution without Citigroup's written permission.

Source: Company Reports, Citi Research

See Appendix A-1 for Analyst Certification, Important Disclosures and Research Analyst Affiliations

Buy Price (06 Oct 26 13:30) NT$2,350.00
Target price NT$2,500.00
Expected share price return 6.4%
Expected dividend yield 0.8%
Expected total return 7.2%
Market Cap NT$999,327M
US$31,497M

Kevin Chen AC

+852-2501-2125 kevin.y.chen@citi.com

Kyna Wong

kyna.wong@citi.com

Karen Huang

karen.xw.huang@citi.com

Yiming Li, CFA

yiming.li@citi.com [讀者資訊已遮蔽]

Figure 2. Chroma ATE - 3Q26 Preliminary Results vs. Estimates

(NT$ mn) 1Q25 2Q25 3Q25 4Q25 1Q26 2Q26 3Q26 - Prelim 3Q26 - BBG 3Q26 - Diff 3Q26 - Citi est 3Q26 - Diff
Revenue 6,865 6,455 6,410 8,580 11,859 13,529 17,926 14,618 23% 14,314 25%
YoY % 55% 17% 14% 42% 73% 110% 180% 128% 123%
Gross Proft 4,148 4,224 3,835 5,217 7,424 8,185 9,032 8,755
GPM 60.4% 65.4% 59.8% 60.8% 62.6% 60.5% 61.8% 61.2%
Opex (1,984) (2,027) (1,987) (2,229) (2,627) (2,943) (3,036) (2,816)
Opex % 28.9% 31.4% 31.0% 26.0% 22.2% 21.8% 20.8% 19.7%
EBIT 2,164 2,197 1,848 2,988 4,797 5,242 5,997 5,938
EBIT margin 31.5% 34.0% 28.8% 34.8% 40.5% 38.7% 41.0% 41.5%
Pre-Tax Profit- Adj. 2,597 2,438 2,288 3,408 5,094 6,514 6,268 6,183
Net Profit - Adj. 2,123 1,953 1,880 2,549 3,864 5,123 5,091 4,923
YoY % 122% 39% 32% 73% 82% 162% 171% 162%
EPS (NT$) - Adj. 4.98 4.60 4.42 5.9 9.07 12.10 11.85 11.63

© 2026 Citigroup Inc. No redistribution without Citigroup's written permission. Source: Company Reports, Bloomberg, Citi Research Estimates

Figure 3. Chroma ATE - 12M Fwd. P/E Band

Figure 4. Chroma ATE - 12M Fwd. P/E Chart

Chroma ATE (2360.TW): August Revenue +156% YoY, Another Record High

Chroma ATE (2360.TW): Chroma Plans 13.6mn Share GDR Issuance; Dilution Manageable with Long-Term Upside Potential

Chroma ATE (2360.TW): 2Q Beat on Non-Op, Positive Outlook Intact [讀者資訊已遮蔽]

© 2026 Citigroup Inc. No redistribution without Citigroup's written permission. Source: dataCentral, Citi Research

Chroma ATE

Valuation

Our target price of NT$2,500 is based on 40x 2027E P/E, at close to 1x PEG. Chroma shares have re-rated above its historical range as its growth outlook is now strongly tied to AI infrastructure build out. We estimate 60%+ of its revenue is now AIrelated, with strong growth across product segments including power testers, SLT, metrology, and photonics. Chroma has a commanding market share in most of these segments and should be well positioned to capitalize on the global AI expansion.

Risks

Downside risks to achieving our target price include: 1) softer AI/CPO growth expectation due to changes in capex outlook or production bottleneck; 2) fewer SLT needed as a result of shortened cycle time as GPU yield rate improves; 3) disappointing metrology shipment due to changes at ramp-up schedule; 4) testing process change leading to loss in market share; 5) FX risks (50-60% of Chroma's sales are in US$, 10-20% in Rmb).

[讀者資訊已遮蔽] If you are visually impaired and would like to speak to a Citi representative regarding the details of the graphics in this document, please call USA 1-888-500-5008 (TTY: 711), from outside the US +1-210-677-3788

Appendix A-1